Accumulation of inactive p53 protein in oral squamous cell carcinoma: Stabilization by protein interaction

European Journal of Oral Sciences

Volumn 121, Issue 1, 2013, Pages 21-28

  Francis, Geo ^a,b   Dileep Kumar, U ^a   Nalinakumari, K R ^a   Jayasree, K ^a   Kannan, S ^a  

^a REGIONAL CANCER CENTRE   (India)

^b Malabar Cancer Centre   (India)

Author keywords

Mutation; Oral cancer; Overexpression; P53 accumulation; Sequencing

Indexed keywords

PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; MUTATION; PAPILLOMAVIRUS INFECTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; ONCOGENE PROTEIN P21(RAS); PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84872670941     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/eos.12007     Document Type: Article

References (41)

1. Babu KG. Oral cancers in India. Semin Oncol 2001; 28: 169-173.
2. D'silva NJ, Ward BB. Tissue biomarkers for diagnosis & management of oral squamous cell carcinoma. Alpha Omegan 2007; 100: 182-189.
3. Patridge M, Costea DE, Huang X. The changing face of p53 in head and neck cancer. Int J Oral Maxillofac Surg 2007; 36: 1123-1138.
4. Soussi T, Beroud C. Assessing TP53 status in human toumours to evaluate clinical outcome. Nature Rev Cancer 2001; 1: 233-240.
5. Vousden KH, Prives C. p53 and prognosis: new insights and further complexity. Cell 2005; 120: 7-10.
6. Jayasurya R, Francis G, Kannan S, Lekshminarayanan K, Nalinakumari K, Abraham T, Abraham EK, Nair MK. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma. Int J Cancer 2004; 109: 710-716.
7. Jayasurya R, Sathyan KM, Lakshminarayanan K, Abraham T, Nalinakumari KR, Abraham EK, Nair MK, Kannan S. Phenotypic alterations in Rb pathway has more prognostic influence than p53 pathway proteins in oral carcinoma. Mod Pathol 2005; 18: 1056-1066.
8. Nylander K, Dabelsteen E, Hall PA. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 2000; 29: 413-425.
9. Soussi T. p53 alterations in human cancer: more questions than answers Oncogene 2007; 26: 2145-2156.
10. Munirajan AK, Tutsumi-Ishii Y, Mohanprasad BK, Hirano Y, Munakata N, Shanmugam G, Tsuchida N. p53 gene mutation in oral carcinoma from India. Int J Cancer 1996; 66: 297-300.
11. Brinkman BM, Wong DT. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol 2006; 18: 228-233.
12. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a casual association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
13. Nagpal JK, Patnaik S, Das BR. Prevalence of high risk human papilloma virus types and its association with p53 codon 72 polymorphism in tobacco addicted OSCC patients of eastern India. Int J Cancer 2002; 97: 649-653.
14. Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, Husain SA, Das BC. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 2003; 252: 117-124.
15. Rogel A, Popliker M, Webb CG, Oren M. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 1985; 5: 2851-2855.
16. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, Saville MK, Lane DP. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005; 19: 2122-2137.
17. Lehman TA, Bennet WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI, Harris CC. p53 mutations, ras mutations and p53 heat shock protein complexes in Human lung carcinoma cell lines. Cancer Res 1991; 51: 4090-4096.
18. Sathyan KM, Nalinakumari KR, Kannan S. H-ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinoma. Mod Pathol 2007; 20: 1141-1148.
19. Sathyan KM, Nalinakumari KR, Abraham T, Kannan S. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncol 2008; 44: 689-697.
20. Bromidge TJ, Howe DJ. Screening of the entire coding region of p53 in low grade lymphoproliferative disorders. J Clin Pathol Mol Pathol 2000; 53: 216-218.
21. Suzui M, Shimizu M, Masuda M, Lim JT, Yoshimi N, Weinstein IB. Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21 (CIP1) in HepG2 human hepatoma cells. Mol Cancer Ther 2004; 3: 309-316.
22. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, Chan SY. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers-high prevalence and multiplicity of infections. Int J Cancer 1995; 61: 450-454.
23. Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N, Rotter V. Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 1986; 6: 4650-4656.
24. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092-1100.
25. Vousden KH, Lane DP. p53 in health and disease. Nature Rev Mol Biol 2007; 8: 275-283.
26. Hall PA, Lane DP. p53 in tumour pathology - can we trust immunohistochemistry-revisited. J Pathol 1994; 172: 1-4.
27. Ralhan R, Agarwal S, Nath N, Mathur M, Wasylyk B, Srivasthva A. Correlation between p53 gene mutations and circulating antibodies in betel and tobacco consuming North Indian population. Oral Oncol 2001; 37: 243-250.
28. Vora HH, Mehta SV, Shukla SN, Shah PM. No mutation detected in five hot spot codons of the TP53 gene by restriction site mutation analysis in patients with carcinoma of the tongue. Int J Biol Markers 2010; 25: 46-51.
29. Kannan S, Yokosaki H, Jayasree K, Sebastian P, Mathews A, Abraham EK, Nair MK, Tahara E. Infrequent loss of heterozygosity of the major tumour suppressor genes in Indian oral cancers. Int J Maxillofac Surg 2001; 31: 414-418.
30. Campisi G, Panzarella V, Giuliani M, Lajolo C, di Fede O, Falaschini S, Di Liberto C, Scully C, Lo Muzio L. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions. Int J Oncol 2007; 30: 813-823.
31. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004; 96: 998-1006.
32. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernández L, Idris A, Sánchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJF, Meijer CJLM, Viscidi R, Munoz N, Franceschi S. Human Papillomavirus and Oral Cancer: The International Agency for Research on Cancer Multicenter Study. J Natl Cancer Inst 2003; 95: 1772-1783.
33. Mishra A, Bharti AC, Vargheese P, Saluja D, Das BC. Differential expression and activation of NF- kappa B family proteins during oral carcinogenesis. Role of high risk human papilloma virus infection. Int J Cancer 2006; 119: 2840-2850.
34. Van Houten VM, Snijders PJ, Van Den Brekel MW, Kummer JA, Meijer CJ, Van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001; 93: 232-235.
35. p53 knowledgebase, Bioinformatics Institute, A*STAR, Singapore (http://p53.bii.a-star.edu.sg/).
36. Haupt Y, Robles A, Prives C, Rotter V. Deconstruction of p53 functions and regulation. Oncogene 2002; 21: 8223-8231.
37. Ralhan R, Sandhya A, Meera M, Bohdan W, Shukla K, Nootan SK. Induction of Induction of MDM2-P2 transcripts correlates with the stabilized wild- type p53 in betel and tobacco related human oral cancer. Amer J Pathol 2000; 157: 587-596.
38. Lee JT, Gu W. The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 2010; 17: 86-92.
39. Hupp TR, Lane DP, Ball KL. Strategies for manipulating the p53 pathways in the treatment of human cancer. Biochem J 2000; 352: 1-17.
40. Kaur J, Srivastava A, Ralhan R. Serum p53 antibodies in patients with oral lesions: correlation with p53/HSP70 complexes. Int J Cancer 1997; 74: 609-613.
41. Asea A. Stress proteins and initiation of immune response: chaperokine activity of Hsp72. Exerc Immunol Rev 2005; 11: 34-45.